Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antidepressant drugs in the elderly

P Gareri1, G Stilo, I Bevacqua

  • 1Department of Clinical and Experimental Medicine, Faculty of Medicine, Policlinico Materdomini, Catanzaro, Italy.

General Pharmacology
|April 2, 1998
PubMed
Summary

This review covers well-tolerated antidepressants for elderly patients, highlighting selective serotonin reuptake inhibitors as preferred options due to fewer side effects and lower toxicity. Tricyclic antidepressants require careful use, with specific agents showing better tolerance in older adults.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Blue mussel (Mytilus edulis L.) exposure to nylon microfibers leads to a shift in digestive gland microbiota.

Environmental pollution (Barking, Essex : 1987)·2025
Same author

Citicoline: pharmacological and clinical review, 2022 update.

Revista de neurologia·2022
Same author

Management of psychogenic non-epileptic seizures: a multidisciplinary approach.

European journal of neurology·2018
Same author

Brand-to-generic levetiracetam switching: a 4-year prospective observational real-life study.

European journal of neurology·2018
Same author

Kaposi's sarcoma after T-cell costimulation blockade with abatacept in rheumatoid arthritis: a case report.

Journal of clinical pharmacy and therapeutics·2017
Same author

The effects of nonsteroidal anti-inflammatory drugs on clinical outcomes, synovial fluid cytokine concentration and signal transduction pathways in knee osteoarthritis. A randomized open label trial.

Osteoarthritis and cartilage·2013

Area of Science:

  • Geriatric Medicine
  • Psychopharmacology
  • Clinical Therapeutics

Background:

  • Depression is a common condition in the elderly, necessitating careful drug selection due to age-related physiological changes and increased risk of adverse events.
  • Older adults often present with comorbidities, such as heart disease, which influence the choice of antidepressant medication.
  • Managing depression in the elderly requires a nuanced approach, balancing efficacy with safety and tolerability.

Purpose of the Study:

  • To review the most important and well-tolerated pharmacotherapeutic options for treating depression in the elderly population.
  • To compare the safety profiles and efficacy of different classes of antidepressants in geriatric patients.
  • To provide guidance on the judicious use of psychotropic medications and other therapies in older adults with depression.

Related Experiment Videos

Main Methods:

  • Review of existing literature on antidepressant pharmacotherapy in elderly patients.
  • Analysis of drug tolerability, side effect profiles, and toxicity in the geriatric population.
  • Comparison of efficacy and safety data for various antidepressant classes, including tricyclic antidepressants, second-generation antidepressants, and monoamine oxidase inhibitors.

Main Results:

  • Tricyclic antidepressants (TCAs) necessitate cautious use due to significant side effects; nortriptyline and desipramine show better tolerability in the elderly.
  • Second-generation antidepressants are generally preferred for the elderly and patients with cardiac conditions due to milder side effects and lower toxicity.
  • Monoamine oxidase inhibitors (MAOIs), particularly reversible ones like moclobemide, are effective for treatment-resistant depression. Lithium has limited use due to side effects.
  • Psychotherapy serves as an adjunct, while electroconvulsive therapy (ECT) is reserved for severe, drug-resistant, or high-suicide-risk cases.

Conclusions:

  • Second-generation antidepressants represent a safer first-line option for geriatric depression compared to traditional TCAs.
  • Careful selection and monitoring are crucial when using TCAs or MAOIs in the elderly, especially for resistant cases.
  • A multimodal approach, including psychotherapy and ECT when indicated, is essential for comprehensive geriatric depression management.